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Dear Editor,
Hidradenitis suppurativa (HS) is a systemic inflammatory disease that has genetic heterogeneity and often requires a multimodal approach [1–3]. Given the recent increase in HS awareness, more providers are recognizing
this entity and referring patients to dermatologists. As a
result, the number of HS specialty clinics has been increasing in the USA during recent years [4]. Information
about existing HS specialty clinics can be found at www.
hs-foundation.org/hs-specialty-clinics. Currently, there
is a gap in academic literature regarding recommendations to efficiently manage HS patients. One method is to
start or improve existing HS specialty clinics via quality
improvement (QI) initiatives that expand organizational
capabilities. After implementing multiple QI initiatives
over a 2-year period, we now serve approximately 750 patients annually across five clinic sites more efficiently and
effectively than before. Here, we describe our experience
with three QI initiatives focused on shortening appointment lead-time delays, improving clinical documentation via patient intake forms and note templates, and creating educational videos explaining HS-specific procedures.
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Our first initiative focused on shortening lead-time
delays, or the time to when new and returning HS patients
are seen in clinic. To improve lead-time delay, most HS
patients were first seen in the general dermatology clinics.
Patients with mild to moderate HS were managed here
over time, while patients with severe, refractory HS were
referred to our HS clinic. However, patients referred from
outside dermatologists or traveling a distance greater
than 50 miles were immediately seen in our HS clinic. We
created an internal set of HS treatment guidelines to be
available at our institution’s general dermatology clinics
to assist providers and residents in managing mild or
moderate HS cases and to route severe cases to our HS
clinic. These guidelines were based upon the North
American HS guidelines, and Henry Ford clinicians experienced in HS management [5]. The QI team coordinated Grand Rounds lectures to ensure all faculty and
residents were educated on the internal guidelines, acute
HS management, and the referral process. For example,
patients with multiple comorbidities, disease recalcitrant
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Fig. 1. Resident survey results on the utility of different educational modalities. a Time needed by residents to
counsel patients on the HS CO2 laser procedure. b Resident perceptions on the utility of different presentation

methods to educate patients.

to conventional therapies, or Hurley Stage III HS requiring CO2 laser excision – a procedure that focuses on tissue
debulking through vaporization and excision of affected
HS lesions – are immediately referred to our HS clinic and
are managed in-house over time [6]. For less emergent
referrals, we created a treatment plan that the referring
provider can follow. We also increased the number of
providers in our HS clinic as patient demand increased
and a single provider clinic became inefficient. Now, two
providers alternate between seeing patients, with one
provider performing a CO2 excision toward the end of
clinic. Clinic appointments are double to triple booked,
with resident and nurse/medical assistant support being
instrumental in maintaining clinic flow. By instituting
these measures over 2 years, lead-time delays decreased
by 30%, from 52.7 days to 36.5 days for new patients, and
decreased by 26% from 54.8 days to 40.6 days for returning patients. The overall clinic workflow and staff wellness improved significantly as providers could spend an
adequate amount of time with patients without running
behind in clinic.
Another recommendation to improve HS clinic efficiency focused on using patient intake forms and electronic medical record (EMR) templates to facilitate history-taking and documentation. At our institution, patients
complete intake forms describing their recent HS history
and treatment, which decrease time spent taking histories
and allow providers to spend more time counseling pa2
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tients. Specifically, our intake form asks questions related
to severity and frequency of pain; location of current and
previous flares; topical, oral, and IV medications used and
side effects; surgical or laser treatment; associated medical symptoms, quality of life impact, and lifestyle factors.
Given that patients may struggle to complete the forms
due to inadequate time or health literacy, our support
staff help patients complete these forms prior to being
roomed. Our providers also use dedicated note templates
to assist with EMR documentation. Note templates have
the added benefit of helping providers determine whether CO2 laser excision and other HS procedures are indicated in more severe or recalcitrant HS cases. While institutional guidelines for CO2 laser procedures may vary, we
promoted our internal guidelines for direct CO2 laser patient referrals through sharing a referral criteria documentation template in the EMR to all providers to assist
with this process.
Lastly, we created educational videos on specific HS
procedures and postsurgical wound care to assist in answering commonly asked questions. Patients are provided
with access to informational videos on CO2 laser excision
performed under tumescent anesthesia and the deroofing
procedure. Previously, residents would sit with patients
and go through PowerPoint presentations, which took a
significant amount of time. With the development of educational videos, residents can complete patient orders and
discharge paperwork, while patients watch the videos and
Boothby-Shoemaker/Rehman/Hamzavi/
Huggins/Mohammad
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Fig. 2. Patient survey results on the utility of different educational modalities. a Patient perceptions of educational modality efficacy in learning about an HS CO2 laser procedure. b Patient perceptions of their preparedness

for the HS CO2 laser procedure after different educational modalities.

ask any questions afterward. We conducted a survey to
assess residents’ perceptions of using the CO2 laser excision video compared to the traditional PowerPoint presentation method. The survey was administered to 31 residents after an approximately 3-month implementation
period. Our analysis revealed that 82% of residents were
able to educate patients on the procedure in less than 7
min using the video, while 67% of residents needed more
than 7 min to educate patients using the PowerPoint
(Fig. 1). Furthermore, 75% of residents thought the video
was an extremely helpful tool and could not think of a better way to educate patients, while only 20% of residents felt
the same way about the PowerPoint (Fig. 1). We also surveyed 20 patients at the end of their visit to assess perceptions of their level of preparedness for the HS CO2 procedure and perceived effectiveness in explaining the HS CO2
procedure (Fig. 2). All of the video group patients (10/10)
reported feeling extremely or very prepared for the procedure compared to 9/10 patients feeling extremely or very
prepared in the PowerPoint group, with 1 patient from the
PowerPoint group reporting feeling slightly prepared.
When asked perceived efficacy in learning about the CO2
procedure, all of the PowerPoint group patients (10/10)
reported this modality to be extremely or very effective,
compared to 9/10 patients in the video group providing
ratings of extremely or very effective, with 1 patient rating
the video as slightly effective. Given these comparable
findings, video presentations may be another useful tool
to help save providers’ time in their HS clinic. An overview
of the recommendations to improve HS clinic efficiency
can be found in Table 1.

Table 1. Overview of recommendations to improve efficiency in HS
clinics

Hidradenitis Suppurativa Clinic
Recommendations
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Recommendations
Build a QI team composed of both general dermatologists and
dermatologists focused in HS care, residents, nurses, medical
assistants, and research staff
Staff multiple providers in the HS clinic to improve clinic workflow
and personnel wellness
Create an HS management ladder to educate non-HS clinic faculty
on how to manage milder HS cases in general dermatology clinics
and refer more severe HS patients to the HS clinic
Use intake forms to improve the accuracy and thoroughness of
patient histories and decrease the time spent on history-taking in
the clinic
Provide adequate time for patients to complete the intake forms
prior to being roomed
Have nursing staff and medical assistants help patients complete
the intake form if needed to improve completion rates
Use note templates to ensure the complete history is
documented, decrease charting time, and assist decision-making
for CO2 laser excision and other HS procedures in moderately
complex patients
Provide patients with educational videos to help save time in
answering frequently asked questions about HS-specific
procedures and necessary wound care

3

We have provided some recommendations to assist institutions in serving HS patients more efficiently in HS
clinics. By sharing our experiences, we hope to encourage
other HS clinics to share their best practices in order to
foster a culture that ultimately promotes higher quality,
accessible healthcare for HS patients.
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Key Message
Quality improvement initiatives for hidradenitis suppurativa
clinics can improve time to evaluation for patients.
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